Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis (Q46495013)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2008

Language	Label	Description	Also known as
English	Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis	scientific article published in August 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

1 reference

based on heuristic

inferred from title

Russell E. Lewis

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

Dimitrios P Kontoyiannis

3

object named as

Dimitrios P Kontoyiannis

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

author name string

Georgios Chamilos

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

language of work or name

0 references

publication date

1 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

47

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

503-509

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

Zygomycetes in human disease

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Halo sign and improved outcome.

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Pulmonary mucormycosis: the last 30 years

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1086%2F590004

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18611163

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46495013&oldid=2113724380"